These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8109455)

  • 1. [New approaches to the regulation of autoimmune disease].
    Kotake S; Matsuda H
    Nippon Ganka Gakkai Zasshi; 1994 Feb; 98(2):121-9. PubMed ID: 8109455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The onset mechanism of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein].
    Usui M
    Nippon Ganka Gakkai Zasshi; 1992 Dec; 96(12):1580-607. PubMed ID: 1283051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen.
    Fling SP; Donoso LA; Gregerson DS
    J Immunol; 1991 Jul; 147(2):483-9. PubMed ID: 1712808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-antigen-specific rat T cell lines recognize peptide fragments of S-antigen and mediate experimental autoimmune uveoretinitis and pinealitis.
    Gregerson DS; Obritsch WF; Fling SP; Cameron JD
    J Immunol; 1986 Apr; 136(8):2875-82. PubMed ID: 2420873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
    Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
    Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental autoimmune uveoretinitis and pinealitis in Lewis rats induced by varied doses of interphotoreceptor retinoid-binding protein].
    Yang PZ
    Zhonghua Yan Ke Za Zhi; 1993 Nov; 29(6):373-6. PubMed ID: 8020385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye: implications for induction of autoimmune uveoretinitis.
    Forrester JV; McMenamin PG; Holthouse I; Lumsden L; Liversidge J
    Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):64-77. PubMed ID: 8300365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new, potent, immunopathogenic epitope in S-antigen that elicits T cells expressing V beta 8 and V alpha 2-like genes.
    Merryman CF; Donoso LA; Zhang XM; Heber-Katz E; Gregerson DS
    J Immunol; 1991 Jan; 146(1):75-80. PubMed ID: 1701801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-presenting cells in experimental autoimmune uveoretinitis.
    Ishimoto S; Zhang J; Gullapalli VK; Pararajasegaram G; Rao NA
    Exp Eye Res; 1998 Nov; 67(5):539-48. PubMed ID: 9878216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
    Gregerson DS; Obritsch WF; Donoso LA
    J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental autoimmune uveitis in Lewis rats by oral administration of recombinant Escherichia coli expressing retinal S-antigen.
    Singh VK; Anand R; Sharma K; Agarwal SS
    Cell Immunol; 1996 Sep; 172(2):158-62. PubMed ID: 8964076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease.
    Saoudi A; Kuhn J; Huygen K; de Kozak Y; Velu T; Goldman M; Druet P; Bellon B
    Eur J Immunol; 1993 Dec; 23(12):3096-103. PubMed ID: 8258322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.
    Fairchild PJ; Thorpe CJ; Travers PJ; Wraith DC
    Immunology; 1994 Apr; 81(4):487-96. PubMed ID: 7518791
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic control of susceptibility to experimental autoimmune uveoretinitis in the mouse model. Concomitant regulation by MHC and non-MHC genes.
    Caspi RR; Grubbs BG; Chan CC; Chader GJ; Wiggert B
    J Immunol; 1992 Apr; 148(8):2384-9. PubMed ID: 1560198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-delta T cells as orally induced suppressor cells in rats: in vitro characterization.
    Wildner G; Thurau SR; Diedrichs-Möhring M
    Ann N Y Acad Sci; 2004 Dec; 1029():416-21. PubMed ID: 15681796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of antigen-specific therapies for autoimmune disease.
    Steinman L
    Mol Biol Med; 1990 Aug; 7(4):333-9. PubMed ID: 2233245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis.
    Butler TL; McMenamin PG
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2195-210. PubMed ID: 8843906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a suppressor cell line which downgrades experimental autoimmune uveoretinitis in the rat.
    Caspi RR; Kuwabara T; Nussenblatt RB
    J Immunol; 1988 Apr; 140(8):2579-84. PubMed ID: 2965724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.